Coffee consumption, serum gamma-glutamyltransferase and risk of type II diabetes (Q45061585)

9 December 2017

title

Coffee consumption, serum gamma-glutamyltransferase and risk of type II diabetes (English)

1 reference

9 December 2017

0 references

5

1 reference

9 December 2017

6

Tuomilehto J

1 reference

9 December 2017

Bidel S

1

1 reference

9 December 2017

Silventoinen K

series ordinal

2

1 reference

9 December 2017

Hu G

series ordinal

3

1 reference

9 December 2017

Lee DH

series ordinal

4

1 reference

9 December 2017

publication date

7 March 2007

1 reference

European Journal of Clinical Nutrition

9 December 2017

published in

1 reference

9 December 2017

volume

62

1 reference

9 December 2017

issue

2

1 reference

9 December 2017

page(s)

178-185

1 reference

Coffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Effects of coffee consumption on glucose tolerance, serum glucose and insulin levels--a cross-sectional analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Coffee consumption and risk of type 2 diabetes in Finnish twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Unexpected effects of coffee consumption on liver enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Free radicals in the physiological control of cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Moderate coffee consumption increases plasma glutathione but not homocysteine in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Evidence that the gamma-glutamyl cycle functions in vivo using intracellular glutathione: effects of amino acids and selective inhibition of enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Joint association of coffee consumption and other factors to the risk of type 2 diabetes: a prospective study in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Urinary sodium and potassium excretion and the risk of type 2 diabetes: a prospective study in Finland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Physical activity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Expression of gamma-glutamyl transpeptidase protects ramos B cells from oxidation-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Caffeine can decrease insulin sensitivity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

gamma-Glutamyl transpeptidase is increased by oxidative stress in rat alveolar L2 epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Identification of differentially expressed genes in skeletal muscle of non-diabetic insulin-resistant and insulin-sensitive Pima Indians by differential display PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Non-alcoholic fatty liver: a common manifestation of a metabolic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Serum gamma-glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Effect of body mass and other factors on serum liver enzyme levels in men attending for well population screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Coffee and incidence of diabetes in Swedish women: a prospective 18-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Coffee consumption and risk for type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Diet, nutrition and the prevention of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Coffee consumption and risk of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Coffee consumption and risk of type 2 diabetes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Radicals and oxidative stress in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Coffee consumption and glucose tolerance status in middle-aged Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Gamma-glutamyl transpeptidase in glutathione biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Prospective Study of Serum -Glutamyltransferase and Risk of NIDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Occupational, commuting, and leisure-time physical activity in relation to risk for Type 2 diabetes in middle-aged Finnish men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: The possible role of hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

The Tromsø Heart Study: distribution of, and determinants for, gamma-glutamyltransferase in a free-living population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

7 January 2021

High D-glucose-induced changes in endothelial Ca2+/EDRF signaling are due to generation of superoxide anions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

7 January 2021

Coffee, diabetes, and weight control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

7 January 2021

Inflammatory pathways and insulin action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

7 January 2021

Green tea polyphenols inhibit the sodium-dependent glucose transporter of intestinal epithelial cells by a competitive mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

7 January 2021

Coffee and serum gamma-glutamyltransferase: a study of self-defense officials in Japan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

7 January 2021

Gamma-glutamyltransferase and diabetes--a 4 year follow-up study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

7 January 2021

gamma-Glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

7 January 2021

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

7 January 2021

Evidence for suppression of hepatic glucose-6-phosphatase with carbohydrate feeding

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

7 January 2021

The Tromsø Study. Distribution and population determinants of gamma-glutamyltransferase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

7 January 2021

Seven-year longitudinal population study of change in gamma-glutamyltransferase: the Tromsø Study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

7 January 2021

Biochemical and haematological response to alcohol intake

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

7 January 2021

Identification of Alcohol Abuse Using Laboratory Tests and a History of Trauma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

7 January 2021

Cardiovascular risk factor changes in Finland, 1972-1997

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

7 January 2021

Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602712

7 January 2021

Identifiers

DOI

10.1038/SJ.EJCN.1602712

1 reference

Dimensions Publication ID

9 December 2017

1014990918

0 references

1 reference